United States · FDA National Drug Code directory
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-326_2c3d4b4a-54e5-1b50-e063-6394a90a170c
- Product NDC
- 72189-326
- Form
- TABLET, FILM COATED
- Composition / generic term
- losartan potassium and hydrochlorothiazide
- Labeler
- Direct Rx
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220221
- Source listing expiry
- 20261231
Source-listed ingredients
- LOSARTAN POTASSIUM — 100 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (72189-326-30) · 72189-326-30
- 90 TABLET, FILM COATED in 1 BOTTLE (72189-326-90) · 72189-326-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →